Abstract
Opioid drugs are commonly used for the relief of pain. The standard medications for severe pain are the derivatives of the opium poppy (opiates) and synthetic drugs that activate the same receptors (opioids). In addition to alleviating perception of pain, however, many opioids also produce a state of well-being or euphoria through central nervous system (CNS) mediated effects. Some individuals may be susceptible to abuse or addiction to the opioids because of these mood-altering effects. Recent research efforts focus on separating the mechanisms underlying analgesia and euphoria in order to develop analgesic medications that do not produce mood-altering effects, and therefore have less abuse liability (O’Brien, 1996). Currently, opioid-related drugs are the standard treatment for severe, acute, and chronic pain associated with cancer, trauma, headache, or other injury. In this chapter we review opioid pharmacology and opioid medications commonly used in analgesia, issues of addiction, including tolerance, withdrawal, and physical dependence, and finally, relevant clinical issues related to the incidence of iatrogenic addiction and individual differences in susceptibility to opioid abuse and addiction.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders ( 4th ed. ). Washington, DC: Author.
Arnér, S., andArnér, B. (1985). Differential effects of epidural morphine in the treatment of cancer-related pain. Acta Anaesthesiologica Scandinavica, 29, 332–336.
Arnér, S., and Meyerson, B. A. (1988). Lack of analgesic effect of opioids on neuropathie and idiopathic forms of pain. Pain, 33, 11–23.
Bloomfield, S. S., Barden, T. P., and Mitchell, J. (1976). Aspirin and codeine in two postpartum pain models. Clinical Pharmacology and Therapeutics, 24, 499–503.
Bozarth, M. A., and Wise, R. A. (1983). Dissociation of the rewarding and physical dependence-producing properties of morphine. In L. S. Harris (Ed.), Problems of drug dependence (NIDA Research Monograph Series No. 43, pp. 171–177). Washington, DC: U.S. Government Printing Office. Breitbart, W. (1987). Suicide in cancer patients. Oncology Review 1,49–55.
Buck, M., and Paice, J. A. (1994). Pharmacologic management of acute pain in the orthopaedic patient. Orthopaedic Nursing, 13, 14–23.
Bukberg, J., Penman, D., and Holland, J. (1984). Depression in hospitalized cancer patients. Psychosomatic Medicine, 46, 199–212.
Cameron, A. J. (1964). Heroin addicts in a casualty department. British Medical Journal, 1, 594.
Canadell-Carafi, J., Moreno-Londono, A., and GonzalezCaudevilla, B. (1991). Ketorolac, a new non-opioid analgesic: A single-blind trial versus buprenorphine in pain after orthopaedic surgery. Current Medical Research and Opinion, 12, 343–349.
Cherny, N. I., and Portenoy, R. K. (1993). Cancer pain management. Cancer, 72, 3393–3415.
Cloninger, C., Bohman, M., and Sivardsson, S. (1981). Inheritance of alcohol abuse: Cross fostering analysis of adopted men. Archives of General Psychiatry 38, 861–868.
Cohen, S. (1980). Drug abuse and the prescribing physician. In S. Cohen, D. Katz, C. Buchwald, and V. Solomon (Eds.), Frequently prescribed and abused drugs: Their indications, efficacy and rational pre-scribing (NIDA Monograph Series No. 2, pp. 1–6 ). Rockville, MD: National Institute on Drug Abuse.
Conroy, J. M., and Harvey, S. C. (1996). Management of cancer pain. Southern Medical Journal, 89, 744–760.
Dai, S., Corrigal, W. A., Coen, K. M., and Kalant, H. (1989). Heroin self-administration by rats: Influence of dose and physical dependence. Pharmacology. Biochemistry and Behavior, 32, 1009–1015.
Deneu, G., Hangita, T., and Seevers, M. H. (1969). Self-administration of psychoactive substances by the monkey. Psvchopharmacology 16, 30–48.
Dennis, S. G., and Melzack, R. (1980). Pain modulation by 5-hydroxytrytaminergic agents and morphine as measured by three pain tests. Experimental Neurology, 69, 260–270.
Dole, V P. (1972). Narcotic addiction, physical dependence and relapse. New England Journal of Medicine, 286, 988–992.
Drug Enforcement Administration. (1987). Guidelines for prescribers of controlled substances. Washington, DC: U.S. Department of Justice.
Foley, K. M. (1981). Current controversies in the management of cancer pain (NIDA Research Monograph Series No. 36, pp. 169–181 ). Rockville, MD: National Institute on Drug Abuse.
Foley, K. M. (1985). The treatment of cancer pain. New England Journal of Medicine, 313, 84–95.
Foley, K. M. (1993). Opioid analgesics in clinical pain management. In A. Herz (Ed.), Handbook of experimental pharmacology: Vol. 104/11. Opioids 11 (pp. 697–743 ). Berlin: Springer-Verlag.
Foley, K. M., and Inturrisi, C. E. (1986). Opioid analgesics in management of clinical pain. Advances in pain research and therapy Vol. 8. New York: Raven.
Fultz, J. M., and Senay. E. C. (1975). Guidelines for management of hospitalized narcotic addicts. Annals of Internal Medicine, 82, 815–818.
Gold, M. S. (1989). Opiates. In A. E. Slaby and J. A. Giannini (Eds.), Drugs of abuse (pp. 127–144 ). Oradell, NJ: Medical Economics Publishing Group.
Gold, M. S., and Miller, N. S. (1997). Intoxication and withdrawal from opiates and inhalants. In N. S. Miller, M. S. Gold, and D. E. Smith (Eds.), Manual of therapeutics for addictions (pp. 72–85 ). New York: Wiley.
Goldstein, A., and Naidu, A. (1989). Multiple opioid receptors: Ligand selectivity profiles and binding site signatures. Molecular Pharmacology, 36, 265–272.
Goodwin, D. W., Schulsinger, F., Hermansen, L., Guze, S. B., and Winokur, G. (1983). Alcohol problems in adoptees raised apart from alcoholic biological parents. Archives of General Psychiatry, 28, 238–243.
Graham, A. W. (1991). Screening for alcoholism by lifestyle risk assessment in a community hospital. Archives of Internal Medicine, 121, 958–963.
lnturrisi, C. E., Mitchell, B. M., Foley, K. M., Schultz, M., Shin, S. U., and Houde, R. W. (1984). The pharmacokinetics of heroin in patients with chronic pain. New England Journal of Medicine, 310, 1213–1217.
Jaffe, J. H. (1985). Drug addiction and drug abuse. In A. G. Gilman, L. S. Goodman, T. W. Rall, and F. Murad (Eds.), The pharmacological basis of therapeutics ( 7th ed., pp. 532–581 ). New York: Macmillan.
Jaffe, J. H. (1990). Drug addiction and drug abuse. In A. G. Gilman, T. W. Rall, A. S. Nies, and P. Taylor (Eds.), The pharmacological basis of therapeutics ( 8th ed., pp. 522–573 ). New York: Macmillan.
Kaiko, R. F., Wallenstein, S. L., Rogers, A. G., Grabinski, P. Y., and Houde, R. W. (1981). Analgesic and mood effects of heroin and morphine in cancer patients with postoperative pain. New England Journal of Medicine, 304, 1501–1505.
Kaiko, R. F., Wallenstien, S. L., Rogers, A. G., Grabinski, P. Y., and Houde, R. W. (1986). Clinical analgesic studies and sources of variation in analgesic responses to morphine. In K. M. Foley and C. E. Inturrisi (Eds.). Opioid analgesics in management of clinical pain: Advances in pain research and therapy (Vol. 8, pp. 13–23 ). New York: Raven.
Kreek, M. J. (1973). Medical safety and side effects of methadone in tolerant individuals. Journal of the American Medical Association, 223, 665–668.
Kreek, M. J. (1978). Medical complications in methadone patients. Annals of the New York Academy of Sciences, 311, 110–134.
Kreek, M. J. (1979). Methadone in treatment: Physiological and pharmacological issues. In R. I. Dupont, A. Goldstein, and J. O’Donnell (Eds.), Handbook on drug abuse (pp. 57–86 ). Washington, DC: U.S. Government Printing Office.
Kreek, M. J. (1992). Rationale for maintenance pharmacotherapy of opiate dependence. In C. P. O’Brien and J. H. Jaffe (Eds.), Addictive states, association for research in nervous and mental disease (Vol. 70, pp. 205–230 ). New York: Raven.
Manion, J. C. (1995). Cancer pain management in the hos- pice setting. Minnesota Medicine, 78, 25–28.
Markenson, J. A. (1996). Mechanisms of chronic pain. American Journal of Medicine, 101, 6S - 18S.
Martin, W. R.. and Jasinski, D. R. (1969). Physiological parameters of morphine dependence in man-Tolerance, early abstinence, protracted abstinence. Journal of Psychiatric Research, 7, 9–17.
Massie, M. J., and Holland, J. C. (1990). Depression and the cancer patient. Journal of Clinical Psychiatry, 7, 12–17. Mattia, A., Vanderah, T.
Mosberg, H. I., and Porreca, F. (1991). Lack of antinociceptive cross-tolerance be- tween [D-Pent, D-PenS]enkephalin and [D-Ala2]deltorphin Il in mice: Evidence for delta receptor subtypes. Journal of Pharmacology and Experimental Therapeutics, 258, 583–587
McCaffrey, M. (1987). Giving meperidine for pain: Should it be so mechanical? Nursing, 17, 6I - 64.
McCaffrey, M., and Beebe, A. (1989). Pharmaceutical control of pain. In Pain: Clinical manual for nursing practice (pp. 42–128 ). St. Louis: C. V. Mosby.
Miller, N. S. (1991). Special problems of the alcohol and multiple-drug dependent: Clinical interactions and detoxification. In R. J. Frances and S. I. Miller (Eds.), Clinical textbook of addictive disorders (pp. 194–218 ). New York: Guilford.
Miller, N. S., and Gold, M. S. (1993). A neurochemical basis for alcohol and other drug addiction. Journal of Psychoactive Drugs, 25, 121–128.
Miotto, K., Compton, P., Ling, W., and Conolly, M. (1996). Diagnosing addictive disease in chronic pain patients. Psychosomatics, 37, 223–235.
Moore, R. D., Bone, L. R., Geller, G., Mamon, J. A., Stokes, E. J., and Levine, D. M. (1989). Prevalence, detection and treatment of alcoholism in hospitalized patients. Journal of the American Medical Association. 261, 403–407.
National Institute of Health Consensus Development Conference. (1987). The integrated approach to the management of pain. Journal of Pain and Symptom Management, 2, 35–44.
O’Brien, C. P. (1996). Drug addiction and drug abuse. In J. G. Hardman, L. E. Limbird, P. B. Molinoff, R. W. Rudden, and A. G. Gilman (Eds.). The pharmacological basis of therapeutics ( 9th ed., pp. 557–577 ). New York: McGraw Hill.
Paul, D., Bodnar, R. J., Gistrak, M. A., and Pasternak, G. W. (1989). Different mu receptor subtypes mediate spinal and supraspinal analgesia in mice. European Journal of Pharmacology, 168, 307–314.
Perry, S., and Heidrich, G. (1982). Management of pain during débridement: A survey of U.S. burn units. Pain, 13, 267–280.
Pert, C. B., and Snyder S. H. (1973). Opiates receptor: Demonstration in nervous tissue. Science, 179, 1011–1014.
Plumb, M. M., and Holland, J. C. (1977). Comparative studies of psychological function in patients with advanced cancer. Psychosomatic Medicine, 39, 264–176.
Portenoy, R. K., and Payne, R. (1992). Acute and chronic pain. In J. H. Lowinson, P. Ruiz, R. B. Millman, and J. G. Langrod (Eds.), Substance abuse: A comprehensive textbook ( 2nd ed., pp. 691–721 ). Baltimore, MD: Williams and Wilkins.
Porter, J., and Hick, H. (1980). Addiction rare in patients treated with narcotics [Letter]. New England Journal of Medicine, 302, 123.
Portnow, J. M., and Strassman, H. D. (1985). Medically induced drug addiction. International Journal of the Addictions, 20, 605–611.
Portoghese, P. S., Sultana, M., Nagase, H., and Takemori, A. E. (1992). A highly selective delta-1 opioid recep-tor antagonist: benzylidenenaltroxone. European Journal of Pharmacology, 218, 195–196.
Redmond, D. E., and Krystal, J. H. (1984). Multiple mechanisms of withdrawal from opioid drugs. Annual Review of Neuroscience, 7, 443–478.
Regier, D., Meyers, J. K., and Kramer, M. (1984). The NIMH epidemiological catchment area study. Archives of General Psychiatry, 41, 934–958.
Reisine, T., and Pasternak, G. (1996). Opioid analgesics and antagonists. In J. G. Hardman, L. E. Limbird, P. B. Molinoff, R. W. Ruddon, and A. G. Gilman (Eds.), The pharmacological basis of therapeutics ( 9th ed., pp. 521–555 ). New York: McGraw Hill.
Reyna, T. M., Hollis, H., and Hulsebus, R. C. (1985). Alcohol related trauma. Annals of Surgery, 201, 194–199.
Sapiro, J. D. (1968). The narcotic addict as a medical pa- tient. American Journal of Medicine, 45, 555–588.
Savage, S. R. (1993). Addiction in the treatment of pain: Significance, recognition, and management. Journal of Pain and Symptom Management, 8, 265–278.
Sawe, J., Hansen, J., Ginman, C., Hartvig, P., Jakobsson, P., Nilsson, M., Rane, A., and Anggard, E. (1981). A patient-controlled dose regimen of methadone in chronic cancer pain. British Medical Journal, 282, 771–773.
Sawynok, J. (1986). The therapeutic use of heroin: A review of the pharmacological literature. Canadian Journal of Physiology and Pharmacology, 64, 1–6.
Schmauss, C., and Yaksh, T. (1984). In vivo studies on spinal opiate receptor systems mediating antinociception: II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous termal stimuli in the rat. Journal of Pharmacology and Experimental Therapeutics, 228, 1–12.
Simon, E. J., Hiller, J. M., and Edelman, I. (1973). Stereo-specific binding of the potent narcotic analgesic [3H]Etorphine to rat brain homogenate. Proceedings of the National Academy of Sciences, 70, 1947–1949.
Sofulglu, M., Portoghese, P. S., and Takemori, A. E. (1991). Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: Evidence for delta opioid receptor subtypes. Journal of Pharmacology and Experimental Therapeutics, 257, 676–680.
Stambaugh, J. E. (1993). Role of nonsteroidal anti-inflammatory drug. In R. B. Patt (Ed.), Cancer pain (pp. 105–117 ). Philadelphia: Lippincott.
Terenius, L. (1973). Stereospecific interaction between narcotic analgesics and a synaptic plasma membrane fraction of rat cerebral cortex. Acta Pharmacologica et Toxicologica, 32, 317–320.
Tucker, C. (1990). Acute pain and substance abuse in surgical patients. Journal of Neuroscience Nursing, 22, 339–350.
Twerski, A. J. (1978). Iatrogenic addiction no less devastating because it’s legal. Pennsylvania Medicine, December, 21–24.
Twycross, R. G., and McQuay, H. J. (1989). Opioids. In P. Wall and R. Melzack (Eds.), Textbook of pain (pp. 686–724 ). New York: Churchill Livingstone.
Vailliant, G. E. (1983). The natural history of alcoholism. Cambridge, MA: Harvard University Press.
Walker, L. (1978). Iatrogenic addiction and its treatment. International Journal of the Addictions, 13, 461–473. Walsh, T. D. (1983). Antidepressants in chronic pain. Clinical Neuropharmacologv, 6, 271–295.
Weissman, D. E., and Haddox J. D. (1989). Opioid pseudoaddiction-An iatrogenic syndrome. Pain, 36, 363–366.
Wilford, B. B. (1987). Prescribing controlled drugs. Chicago: American Medical Association.
Wilford, B. B. (1990). Abuse of prescription drugs. Western Journal of Medicine, 152, 609–612.
Wise, R. A. (1989). The brain and reward. In J. M. Lied-ban and S. J. Cooper (Eds.), The neuropharmacological basis of reward. Oxford, England: Oxford University Press.
Wood, P. L., Richard, J. W., and Thakur, M. (1982). Mu opiate iso receptors: Differentiation with kappa agonists. Life Sciences, 31, 2313–2317.
World Health Organization. (1986). Cancer pain relief Geneva, Switzerland: Author.
World Health Organization. (1990). Technical report series. Cancer pain relief and palliative care. Geneva, Switzerland: Author.
Zaki, P. A., Bilsky, E. J., Vanderah, T. W., Lai, J., Evans, C. J., and Porreca, F. (1996). Opioid receptor types and subtypes: The delta receptor as a model. Annual Review of Pharmacology and Toxicology. 36, 379–401.
Ziegler, D. K. (1994). Opiate and opioid use in patients with refractory headache. Cephalalgia, 14, 5–10.
Zukin, R. S., Eghbali, M., Olive, D., Unterwald E. M., and Tempel, A. (1988). Characterization and visualization of rat and guinea pig brain kappa opioid receptors: Evidence for kappa I and kappa 2 opioid receptors. Proceedings of the National Academy of Sciences of the United States of America, 85, 4061–4065.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
King, A.C., Miller, N.S. (1998). Medications of Abuse. In: Tarter, R.E., Ammerman, R.T., Ott, P.J. (eds) Handbook of Substance Abuse. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-2913-9_26
Download citation
DOI: https://doi.org/10.1007/978-1-4757-2913-9_26
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-3297-6
Online ISBN: 978-1-4757-2913-9
eBook Packages: Springer Book Archive